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Abstract
Introduction Ankylosing spondylitis (AS) is a severe, chronic
inflammatory disease strongly associated with HLA-B27. The
presence of additional HLA risk factors has been suggested by
several studies. The aim of the current study is to assess the
occurrence of an additional HLA susceptibility locus in the
region between HLA-E and HLA-C in the Sardinian population.
Methods 200 random controls, 120 patients with AS and 175
HLA-B27 positive controls were genotyped for six single
nucleotide polymorphisms (SNPs) spanning the HLA region
between HLA-E and HLA-C loci previously shown to harbour an
additional susceptibility locus for AS. Allele, genotype and
haplotype frequencies were compared.
Results The data confirm our previous finding of a significant
increase in patients with AS of allele A at SNP rs1264457
encoding for an Arg at the functional HLA-E polymorphism
(Arg128/Gly128). This was due to a remarkable increase in the
frequency of genotype A/A in patients vs HLA-B27-matched
controls (51% vs 29%; P  for trend: 5 × 10-5). Genotype
distribution of three other SNPs mapping in genes (GNL1,
PRR3 and ABCF-1) close to HLA-E and showing high LD with
it, was also significantly skewed. Accordingly, haplotype
distribution was also remarkably different. The frequency of the
haplotype AAGA, is 42% in random controls, increases to 53%
in the HLA-B27-positive controls, and reaches 68% in patients
with AS (P values: 2 × 10-11 vs random and 3 × 10-4 vs HLA-
B27 controls).
Conclusions There is a strong association between the
presence of a haplotype in genes mapping between HLA-E and
HLA-C and AS due to an increase of homozygous markers in
patients. The strongest association however, is with the HLA-E
functional polymorphism rs1264457. Since HLA-E is the ligand
for the NKG2A receptor, these data point to the natural killer
(NK) activity as possible player in the pathogenesis of AS.
Introduction
Ankylosing spondylitis (AS) is a severe, chronic inflammatory
disease whose strong association with human leukocyte anti-
gen (HLA)-B27 has been known for many years. However, the
presence of HLA-B27 far from accounts for the entire genetic
load in AS. Other genes within and outside the HLA region
have been evoked as additional factors contributing to the dis-
ease [1-4]. Although the association of genes outside the HLA
region, such as IL-1, IL23R or endoplasmic reticulum ami-
nopeptidase 1 (ERAP1), has been demonstrated, it appears
more difficult to single out independent HLA risk factors, due
to the strong Linkage Disequilibrium (LD) among genes map-
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ping within the HLA region. The Sardinian is an outlier popula-
tion and, due to the relative low gene flow from outside
populations [5], is particularly suitable for case-control associ-
ation studies in common complex diseases. In previous work,
by comparing HLA-B27 -positive patients with AS and con-
trols, we have reported that the region between HLA-E and
major histocompatibility class I polypeptide-related sequence
A (MICA) contains genes showing different allele frequencies
between the two cohorts, and that there was an excess of
homozygous markers in patients [6]. This allowed us to spec-
ulate that the co-occurring chromosome was contributing to
the disease providing a double dose of the predisposing allele.
Interestingly, among the markers analysed, we found that the
functional single nucleotide polymorphism (SNP) in the HLA-
E gene (rs1264457A/G; determining the amino acid variation
Arg128Gly) showed a significantly different genotype distribu-
tion in the two cohorts. Here, we analyse a larger cohort of
HLA-B27-positive patients (n = 120) and HLA-B27-positive
controls (n = 175) for the distribution of rs1264457 and five
other SNPs mapping in genes close to the HLA-E locus. This
further analysis confirms the strong association between allele
A at rs1264457 in the HLA-E gene and AS.
Materials and methods
In this study, 200 random controls, 120 HLA-B27-positive
patients with AS and 175 HLA-B27-matched controls were
analysed. Seventy-nine HLA-B27-positive patients and 77
controls (24 of which were typed as B*2709) have been pre-
viously described [6]. A further 41 patients with AS and 98
HLA-B27-positive controls (16 of which typed as B*2709)
were enrolled in this study. The final subtype distribution was
as follow: 108 B*2705 (90%), 6 B*2702 (5%), 4 B*2707
(3%) and 2 B*2713 (2%) in the cohort of patients with AS;
and 121 B*2705 (69%), 40 B*2709 (23%), 9 B*2707 (5%)
and 5 B*2702 (3%) in the cohort of HLA-B27-positive con-
trols. Population stratification had been controlled by analyzing
the distribution of a SNP mapping at the 5' end (rs4988235)
of the gene for lactase and no significant difference in geno-
type distribution between patients and controls was found [7].
DNA samples from patients and controls were collected at the
University of Cagliari, Cagliari, Sardinia. The B*2709 haplo-
type, not associated with AS [8], was not different from
B*2705 for the markers analyzed here [6] and therefore
B*2709 controls were included in the study. Genotype distri-
bution of all six SNPs was in Hardy-Weinberg equilibrium. All
patients were diagnosed according to the modified New York
criteria [9]. All subjects gave their informed consent to the
study. The study was approved by the local ethics committee.
PCR
A 20 ng sample of genomic DNA in a volume of 15 ul, contain-
ing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 2.5 mM MgCl2, 0.2
mM dNTPs, 5 pmoles each of forward and reverse primer and
0.75 U of Taq Polymerase (Biotaq DNA Polymerase, Bioline
(Bioline Ltd, London, UK) was used. The mixture was incu-
bated at 94°C for three minutes followed by 25 to 30 cycles
of denaturation at 94°C for 30 seconds, annealing at a range
of 55 to 62°C (depending on the analysed marker) for 30 sec-
onds, extension at 72°C for one minute, with a final step of
72°C for 10 minutes.
SNP typing
Five SNPs mapping in the region encompassing about 100 kb
between the HLA-E and HLA-C genes have been analysed:
rs2105960 in the member RAS oncogene family pseudogene
1 (RANP1) gene, rs1264457 in the HLA-E gene, rs2074505
in the guanine nucleotide binding protein-like 1 (GNL1) gene,
rs2074503 in the proline-rich polypeptide 3 (PRR3) gene, and
rs 2269709 and rs1264439 in the ATP-binding cassette, sub-
family F (GCN20), member 1 (ABCF-1) gene. SNPs were
typed by minisequencing as previously reported [6]. Briefly,
the amplified products were treated with 0.5 U of shrimp alka-
line phosphatase (SAP; Roche, Gaillard, France) and 2.5 U of
exonuclease I (EXO I; BioLabs, Frankfurt am Main, Germany)
at 37°C for 120 minutes and at 75°C for 15 minutes for inac-
tivation. For minisequencing reactions, the commercial fluores-
cent-based minisequencing kit SNaPshot multiplex (Applied
Biosystems, Lincoln Centre Drive, Foster City, USA) was
used, with 2 pmoles of primer. PCR for single base extension
reaction was as follows: initial denaturation at 94°C for three
minutes, followed by 50 cycles of primer extension at 96°C for
15 seconds, annealing at 55 to 59°C (depending on the oligo-
nucleotide annealing temperature) for 15 seconds, extension
at 60°C for one minute. After the extension and labelling reac-
tion, the unincorporated dNTPs were removed by enzymatic
treatment using 0.5 U of SAP at 37°C for 120 minutes and at
75°C for 15 minutes for inactivation. The products were ana-
lyzed on the ABI prism 310 Genetic Analysers (Applied Bio-
systems, Lincoln Centre Drive, Foster City, USA). Genotyping
was performed by 310 ABI Prism GeneScan 2.1 software
(Applied Biosystems,, Lincoln Centre Drive, Foster City, USA).
Primers were as follows: rs2105960: FOR: AGACGCTTCT-
GGAAGGAACA; REV: GGCTGTGTCCCATACATTGA;
SEQ: ATGGTGGTACTGGAAAAACG. rs1264457: FOR: 5'-
GTGGGCGGGACTGACTAAG; REV: 5'-GGTCCTCAT-
TCAGGGTGAGA; SEQ: 5'-TGCGAGCTGGGGCCCGAC.
rs2074505: FOR: CACAGTGATGGCTTCACAGGC; REV:
5'-CCTATAGGAAGCCCTCTGAGAC; SEQ: CCCCCG-
CACCCCACAGGA. rs2074503: FOR: GCACAAGAAACA




rs1264439: FOR: GATTACAGGCGTGACCCATT; REV:
CCCTTTTCCTCTTTCCCTTC; SEQ: CTCACCACCAAG-
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Statistical analysis
Two-tailed Fisher's Exact test was used to assess the differ-
ences of proportion of polymorphic alleles and association
between random controls and HLA-B27 patients, HLA-
B*2705 and HLA-B*2709 controls. The Cochrane-Armitage
trend test was performed using StatXact7 software (Massa-
chusetts Ave, Cambridge, USA). P values less than 0.05 were
considered significant. LD was calculated using Haploview
software [10]. Hardy-Weinberg equilibrium testing was per-
formed using Pearson's goodness-of-fit chi-squared test with
one degree of freedom.
Results
We report here allele, genotype and haplotype distribution of
six markers spanning the region between HLA-E and HLA-C
genes in 175 HLA-B27-positive controls and 120 patients
with AS. LD r2 values calculated using 200 random controls,
are reported in Figure 1. Marker rs2105960 mapping in the
pseudogene RANP1 shows no LD with the others. A central
block of LD is evident going from HLA-E rs1264457 to
rs2269709 in the ABCF1 gene. Allele frequencies of these six
SNPs in HLA-B27-positive patients with AS and controls is
reported in Table 1. RANP1 rs 2105960, mapping upstream
HLA-E and not in LD with it, shows a similar allele frequency in
patients with AS and HLA-B27 controls. According to our pre-
vious data [6], HLA-E rs1264457 shows the highest associa-
tion with AS (P = 1 × 10-4; odds ratio = 2; 95% confidence
interval = 1.4 to 2.9). In parallel with the decrease of the LD,
the strength of association of the other markers mapping
downstream the HLA-E gene, also decreases. Rs1264439,
mapping in the ABCF1 gene, is almost monomorphic and
shows no association. As expected, genotype distribution of
the HLA-E rs1264457 is significantly different between
patients with AS and HLA-B27-positive controls (P-trend = 5
× 10-5) with a strong increase in genotype AA in patients (51%
vs 29%). Genotype AG is present in 60% of B27 controls vs
46% of patients with AS. The other markers in high LD with it,
also show significant P-trend values which, however, down-
grade the more the distance from rs1264457. As expected,
haplotype distribution of the four SNPs showing association,
rs1264457/rs2074505/rs2074503/rs2269709, is also dif-
ferent between patients and controls (Table 2). HLA-E
rs1264457 allele A is a marker of the HLA-B27 haplotype in
Sardinia. Accordingly, the haplotype AAGA is significantly
over-represented among the HLA-B27-positive controls (53%
calculated using the overall cohort of the HLA-B27 controls
compared with 42% in random controls. P value = 9 × 10-4).
Haplotype distribution in the HLA-B*2709-positive cohort is
reported in Table 2. Although the number of subjects analysed
is low (n = 40), it is evident that the distribution is, if any, more
similar to that of the AS patients than to the HLA-B27 controls
indicating that the same AAGA haplotype is a feature of both
the B*2705- and the B*2709-positive cohorts. For this reason,
the statistical analysis has always been performed pooling all
B27 controls in one single cohort. Due to the homozygous sta-
tus of the corresponding markers, patients with AS show an
even higher frequency of the 'B27 haplotype' (AAGA: 68%).
The other frequent haplotype, GGAG, is under-represented in
patients compared with the HLA-B27 controls, in which the
increase of the haplotype AAGA is counterbalanced by a pro-
portional lower frequency of all the other haplotypes.
Discussion
The data reported here validate our previous observation of a
strong association between a functional polymorphism of the
HLA-E gene and AS in Sardinia. It has been shown that the
signal peptide of the HLA-B27 molecules binds with low affin-
ity to the HLA-E Arg128 variant [11] and therefore the
absence of the alternative variant, Gly128 in patients, could
result in a reduced expression of the HLA-E molecules on the
cell surface. This, in turn, could lead to an imbalance of the
inhibitory function of HLA-E on natural killer (NK) activity or to
an alteration of regulatory functions as it has been shown in
animal models of autoimmune diseases [12]. More and more
reports are involving the HLA-E-NKG2A pathway in autoim-
mune/inflammatory diseases. Recently, a polymorphism map-
ping in the HLA-E gene has been found to be associated with
Figure 1
Linkage disequilibrium values among the markers mapping in the region  between HLA-E and HLA-C in the Sardinian population Linkage disequilibrium values among the markers mapping in the region 
between HLA-E and HLA-C in the Sardinian population. Linkage Dise-
quilibrium r2 values among the six SNPs spanning the region between 
the HLA-E and HLA-C genes considered in this study. Calculation has 
been made analyzing two hundreds random controls (400 haplotypes) 
using haploview software [10]. Color scale reflects the strength of LD 
among the six markers whose genotype distribution was in Hardy-
Weinberg Equilibrium.Arthritis Research & Therapy    Vol 11 No 6    Paladini et al.
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HLA-B27+ patients with AS
n = 120
Gene SNP Position on chromosome 6 MAF (%) MAF (%) P OR (95% CI)
RANP1 rs2105960 30561768 245 (75) 154 (69) ns
TT 94 (57) 49 (44)
CT 63 (38) 56 (50)
CC 9 (5) 7 (6)
P trend ns
HLA-E rs1264457 30566040 207 (59) 177 (74) 1 × 10-4 21 . 4 - 2 . 9
AA 51 (29) 61 (51) Ref
AG 105 (60) 55 (46) 1 × 10-3 0.44 (0.27-0.72)
GG 19 (11) 3 (3) 4 × 10-4 0.13 (0.04-0.5)
P trend 5 × 10-5
GNL1 rs2074505 30629116 219 (63) 179 (76) 4 × 10-4 1.9 1.4-2.8
AA 68 (39) 68 (58) Ref
AG 83 (47) 43 (37) 0.01 0.52 (0.31-0.85)
GG 24 (14) 6 (5) 4 × 10-3 0.25 (0.1-0.65)
P trend 4 × 10-4
PRR3 rs2074503 30638475 247 (76) 203 (85) 9 × 10-3 1.8 1.2-2.7
GG 93 (57) 85 (71) Ref
AG 61 (37) 33 (28) 0.05 0.59 (0.35-1)
AA 10 (6) 2 (1) 0.04 0.22 (0.05-1)
P trend 7 × 10-3
ABCF1 rs2269709 30648869 224 (74) 201 (84) 5 × 10-3 1.8 1.2-2.8
AA 82 (54) 83 (69) Ref
AG 60 (39) 35 (29) 0.04 0.58 (0.34-0.99)
GG 10 (7) 2 (2) 0.03 0.2 (0.04-0-9)
P trend 4 × 10-3
ABCF1 rs1264439 30660481 312 (91) 212 (91) ns
GG 142 (83) 97 (84)
GT 28 (16) 18 (15)
TT 1 (1) 1 (1)
P trend ns
AS = ankylosing spondylitis; CI = confidence interval; MAF = major allele frequency; ns = not significant; OR = odds ratio; SNP = single 
nucleotide polymorphism.Available online http://arthritis-research.com/content/11/6/R171
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Kawasaki disease [13] and the HLA-E-NKG2A pathway is
likely to play a role in celiac disease [14]. From the data
reported here, it seems unlikely that a HLA-E neighboring gene
rather than HLA-E itself, could be the real factor contributing
to the disease. The data reported here strongly suggest that
NK activity could be involved in the pathogenesis of AS [15]
although the HLA-E molecules themselves are not necessarily
responsible for this in all populations. As an example, two stud-
ies performed in a Spanish and an Asian population reports an
imbalance of KIR alleles between patients with AS and HLA-
B27-matched controls but these data have not been repli-
cated in a further study in an English cohort [16-18]. This
might indicate that different pathways have been selected in
different populations based on their genetic background and
environmental pressure, leading to the impairment of a crucial
function, which can be imbalanced towards an exceeding
effector or a defective regulatory function. If this is the case,
the more promiscuous the population is, the more difficult it
can be to identify some of the minor predisposing genes. For
this reason, isolated populations which have undergone
strong selection by environmental factors as it occurred in Sar-
dinia, might be particularly informative to single out genes that
predispose to complex diseases particularly in those cases in
which a gene with a strong effect, such as HLA-B27, plays a
leading role [19].
Conclusions
There is a strong association between a gene mapping in the
region between HLA-E and HLA-C and AS in Sardinia. This
gene is most likely to be the HLA-E itself because the func-
tional polymorphism rs1264457 encoding for an Arg at posi-
tion 128 found to be functionally relevant shows the strongest
association.
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